Company No: SC579653 (Scotland)

Contents

• Company information
• Accountant's Report
• Balance Sheet

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Terraprotein Equity Partners Limited for the financial period ended 31 December 2019 which comprises the Balance Sheet and the related notes from the Company’s accounting records and from information and explanations you have given us.

We are subject to the ethical and other professional requirements of the Institute of Chartered Accountants in England and Wales (ICAEW) which are detailed at _http://www.icaew.com/en/members/regulations-standards-and-guidance/_

It is your duty to ensure that Terraprotein Equity Partners Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Terraprotein Equity Partners Limited. You consider that Terraprotein Equity Partners Limited is exempt from the statutory audit requirement for the financial period.

We have not been instructed to carry out an audit or a review of the financial statements of Terraprotein Equity Partners Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

This report is made solely to the Board of Directors of Terraprotein Equity Partners Limited, as a body, in accordance with the terms of our engagement letter dated 31 October 2017. Our work has been undertaken solely to prepare for your approval the financial statements of Terraprotein Equity Partners Limited and state those matters that we have agreed to state to you in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Terraprotein Equity Partners Limited and its Board of Directors as a body for our work or for this report.

Deloitte LLP
Accountant

1 New Street Square
London
EC4A 3HQ
United Kingdom

12 October 2020

Notes to the financial statements

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC579653). The address of its registered office is C/O Morton Fraser Llp 5th Floor, Quartermile Two, 2 Lister Square, Edinburgh, EH3 9GL, United Kingdom.

2. Employees

3. Directors’ benefits: advances, credit and guarantees

Advances

Included within other debtors is an unsecured shareholder's loan of £44,657 (2018: £44,657) owed by SBL Family Holding Limited. The loan is interest-free and is repayable on demand.

Included within other debtors is an unsecured shareholder's loan of £54,103 (2018: £97,689) owed by Stockbridge Australia PTY Limited. The loan is interest-free and is repayable on demand.

4. Going concern

Since the period under review, the potential rapid spreading of COVID-19 has become a significant emerging risk to the global economy. The directors continue to monitor the impact of the virus on the business as more information about the epidemic emerges. At the time of signing the directors do not consider COVID-19 to impact the Company’s ability to continue as a going concern. The directors note this is a non-adjusting post balance sheet event.

The directors have assessed the balance sheet and likely future cash flows at the date of approving these financial statements. The Company is financially supported by shareholder loans which the directors believe will not be required to be repaid within the next 12 months of the financial statements being signed, unless the Company has sufficient funds to do so. As a holding company, the Company has minimal fixed costs which are expected to be met from income generated by fixed assets over the coming 12 months. Based on this, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

For the financial period ending 31 December 2019 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors’ responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with 476;
• The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Terraprotein Equity Partners Limited (registered number: SC579653) were approved and authorised for issue by the Board of Directors on 12 October 2020 and were signed on its behalf by: